Oral Contraceptive Pills: Access and Availability
This brief provides an overview of oral contraception, discusses private insurance and Medicaid coverage, and reviews strategies to promote and expand women’s access to oral contraceptives.
Read More
Journalists Share Latest on Baby Formula Safety, Estrogen Patches, and Postcancer Costs
Céline Gounder, KFF Health News’ editor-at-large for public health, discussed the results of the FDA’s largest baby formula safety test on CBS News 24/7’s The Daily Report on April 29. She also discussed how women seeking treatment for menopause symptoms are facing a shortage of estrogen patches on CBS News’ CBS Mornings on April 27….
Goodpath Rakes In $18M for Chronic Condition Platform
Goodpath’s Series A round was led by MassMutual Ventures and included participation from Healthy Ventures. In total, the company has raised $22 million. The post Goodpath Rakes In $18M for Chronic Condition Platform appeared first on MedCity News.
The Top-Rated Orthopedic Surgery Centers in the Houston Area and Beyond
[Sponsored] Discover Houston’s best orthopedic surgery centers and what features — from personalized treatment plans to rehabilitation services — make these top providers stand out in their industry. The post The Top-Rated Orthopedic Surgery Centers in the Houston Area and Beyond appeared first on MedCity News.
When It Comes to AI, Rural Doctors Have FOMO — Meditech & Suki Are Teaming Up to Address This
Meditech is integrating Suki’s AI assistant into more than a dozen rural health systems, including St. Mary’s Healthcare in New York and Decatur County Memorial Hospital in Indiana. The post When It Comes to AI, Rural Doctors Have FOMO — Meditech & Suki Are Teaming Up to Address This appeared first on MedCity News.
How Ochsner Health Radiology Is Scaling Up Incidental Findings Program
Kernesha Weatherly, D.H.A., vice president of imaging services and provider practice, explains impact of widespread implementation
Organon Stops Work on Endometriosis Drug After Failure in Phase 2 Test
Organon said OG-6219 did not beat a placebo in a mid-stage clinical trial whose main goal was to measure the change in pelvic pain caused by endometriosis. The twice-daily pill came from Organon’s 2021 acquisition of Forendo Pharma. The post Organon Stops Work on Endometriosis Drug After Failure in Phase 2 Test appeared first on…
Bristol Myers Squibb’s Sotyktu Meets Goals in Two Pivotal Psoriatic Arthritis Studies
Sotyktu, which became the first TYK2 inhibitor to reach the market after its 2022 FDA approval in plaque psoriasis, now has positive data from two pivotal tests in psoriatic arthritis. Bristol Myers Squibb is trying to add new indications for the drug and stay ahead of competitors including Takeda Pharmaceutical. The post Bristol Myers Squibb’s…
Set the Data Free: Break the Chains of Information Silos
When you combine clean data with longitudinal patient records and transparent access — that’s when you start seeing real transformation in care delivery. The post Set the Data Free: Break the Chains of Information Silos appeared first on MedCity News.
Five New Members Join CDC Vaccine Advisory Panel
New members were chosen just days before vaccine advisers to the CDC’s Advisory Committee on Immunization Practices meet